GE HealthCare Technologies Inc. $GEHC Shares Purchased by Vontobel Holding Ltd.

Vontobel Holding Ltd. boosted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 29.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 28,187 shares of the company’s stock after buying an additional 6,496 shares during the period. Vontobel Holding Ltd.’s holdings in GE HealthCare Technologies were worth $2,117,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of GEHC. Net Worth Advisory Group purchased a new stake in shares of GE HealthCare Technologies in the 3rd quarter valued at approximately $303,000. IFM Investors Pty Ltd boosted its position in shares of GE HealthCare Technologies by 3.1% during the 3rd quarter. IFM Investors Pty Ltd now owns 96,490 shares of the company’s stock worth $6,992,000 after purchasing an additional 2,893 shares during the period. True North Advisors LLC increased its holdings in GE HealthCare Technologies by 2.0% in the 3rd quarter. True North Advisors LLC now owns 6,987 shares of the company’s stock valued at $525,000 after purchasing an additional 139 shares during the last quarter. Farther Finance Advisors LLC increased its holdings in GE HealthCare Technologies by 5.4% in the 3rd quarter. Farther Finance Advisors LLC now owns 5,508 shares of the company’s stock valued at $414,000 after purchasing an additional 280 shares during the last quarter. Finally, OFI Invest Asset Management raised its position in GE HealthCare Technologies by 38.5% in the third quarter. OFI Invest Asset Management now owns 1,769 shares of the company’s stock valued at $133,000 after purchasing an additional 492 shares during the period. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Up 0.3%

GEHC opened at $83.61 on Friday. The business has a fifty day moving average price of $78.74 and a 200 day moving average price of $75.81. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.18 and a quick ratio of 0.95. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80. The stock has a market capitalization of $38.09 billion, a price-to-earnings ratio of 17.27, a PEG ratio of 3.48 and a beta of 1.10.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. The company had revenue of $5.14 billion for the quarter, compared to analyst estimates of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.GE HealthCare Technologies’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter last year, the company earned $1.14 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be paid a $0.035 dividend. The ex-dividend date is Friday, January 9th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is currently 2.89%.

Analyst Ratings Changes

Several research analysts have recently commented on the company. Jefferies Financial Group raised their price target on GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a research report on Thursday, December 11th. Wall Street Zen lowered GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, September 20th. Zacks Research cut GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, September 29th. Stifel Nicolaus set a $90.00 price target on shares of GE HealthCare Technologies in a research note on Friday, November 21st. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Monday. Six analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $87.09.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.